Trevi Therapeutics, Inc. reported raising $55 Million in an initial SEC Form D filing, from an offering of $55 Million
Amount Raised
$55 Million
Round Type
Venture
New HavenBiotechnologyWho else raised in Biotechnology around the same time
Companies in the same sectors as Trevi Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Massive Bio and Foundation Medicine raised $9M (Funding Round) on June 2, 2022.
- Axe Compute Inc. raised $2.3M on June 2, 2022.
- Vernal Biosciences, Inc. raised $21M (Funding Round) on June 2, 2022.
- Endpoint Health raised $52M (Funding Round) on June 2, 2022.
- Upstream Bio raised $200M (Series A) on June 2, 2022.
- Sanara MedTech raised $14M on June 2, 2022.
Who to call at Trevi Therapeutics, and when
A new round usually means Trevi Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Trevi Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Trevi Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Trevi Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Trevi Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Trevi Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.